Canada · Series B startup

Who invested in Alethia BioTherapeutics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2010, from 2 sources

$9.2MSeries A$4.7MSeries B
Latest round
Series B, $4.7MNov 2012
Biggest round
$9.2MSeries A · Sept 2010
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112012
$9.2MSeries A$4.7MSeries B
First round
Series A, $9.2M
Sept 2010
Biggest round
$9.2M
Series A · Sept 2010
Between rounds
2.2 years
from the last two

The rounds

  1. Nov 2012
    Series B$4.7M3 returning

    Reported by finance.yahoo.com

  2. Sept 2010
    Series A$9.2M4 new

    Reported by fis.dowjones.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2010Series B2012BDC CapitalGeneChemGO Capital FundEpicentre Technologies

Everyone who backed them

BDC CapitalVC firm2rounds
GeneChemGrowth equity2rounds
GO Capital FundVC firm2rounds
Epicentre Technologiesno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Alethia BioTherapeutics

Who invested in Alethia BioTherapeutics?

Alethia BioTherapeutics's investors include BDC Capital, GeneChem, GO Capital Fund and Epicentre Technologies.

How much has Alethia BioTherapeutics raised?

Alethia BioTherapeutics has raised $14M across 2 rounds since 2010.

When did Alethia BioTherapeutics last raise?

Alethia BioTherapeutics's most recent round was a Series B of $4.7M in Nov 2012.

What was Alethia BioTherapeutics's biggest round?

Alethia BioTherapeutics's largest round on record is $9.2M (Series A), in Sept 2010.

Who backed Alethia BioTherapeutics first?

Alethia BioTherapeutics's first round on record, in Sept 2010, was backed by BDC Capital, GeneChem and GO Capital Fund and 1 others.

What stage is Alethia BioTherapeutics at?

Alethia BioTherapeutics's latest named round is a Series B, in Nov 2012.

Where is Alethia BioTherapeutics based?

Alethia BioTherapeutics is based in Canada.

Companies like Alethia BioTherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.